We are live on ! Find out more
OC

Oarsman Capital Portfolio holdings

AUM $806M
1-Year Est. Return 19.96%
This Fund
S&P 500
This Quarter Est. Return
+4.73%
1 Year Est. Return
+19.96%
3 Year Est. Return
+61.37%
5 Year Est. Return
+74.92%
10 Year Est. Return
+242.94%
AUM
$138M
AUM Growth
+$8.29M
Cap. Flow
+$2.49M
Cap. Flow %
1.8%
Top 10 Hldgs %
20.42%
Holding
173
New
6
Increased
77
Reduced
58
Closed
4

Sector Composition

Rank Sector Weight
1 Healthcare 13.09%
2 Technology 11.04%
3 Industrials 9.78%
4 Consumer Staples 7.54%
5 Energy 6.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GE icon
1
GE Aerospace
GE
$367B
$4.64M 3.37%
36,858
+413
+1% +$52.5K
WBA
2
DELISTED
Walgreens Boots Alliance
WBA
$3.45M 2.51%
46,587
-438
-0.9% -$30.6K
JNJ icon
3
Johnson & Johnson
JNJ
$634B
$3.17M 2.3%
30,255
-207
-0.7% -$20.9K
RPM icon
4
RPM International
RPM
$13.7B
$2.76M 2%
59,717
-1,226
-2% -$53.1K
AAPL icon
5
Apple
AAPL
$4.89T
$2.71M 1.97%
116,684
-6,572
-5% -$140K
GOOG icon
6
Alphabet (Google) Class C
GOOG
$3.9T
$2.48M 1.8%
85,895
+2,182
+3% +$59.2K
MGK icon
7
Vanguard Mega Cap Growth ETF
MGK
$31.9B
$2.33M 1.69%
151,950
+4,335
+3% +$64.1K
PEP icon
8
PepsiCo
PEP
$186B
$2.25M 1.63%
25,159
+279
+1% +$24.1K
PG icon
9
Procter & Gamble
PG
$343B
$2.21M 1.6%
28,114
+818
+3% +$66K
MSFT icon
10
Microsoft
MSFT
$2.84T
$2.14M 1.55%
51,299
-465
-0.9% -$18.8K
FISV
11
Fiserv Inc
FISV
$27.2B
$2.02M 1.47%
67,012
+20,962
+46% +$621K
LQD icon
12
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$34.7B
$1.99M 1.44%
16,648
+239
+1% +$28.3K
KMB icon
13
Kimberly-Clark
KMB
$36.4B
$1.95M 1.42%
18,308
-43
-0.2% -$4.57K
CVX icon
14
Chevron
CVX
$388B
$1.95M 1.41%
14,900
+7
+0% +$871
INTC icon
15
Intel
INTC
$464B
$1.94M 1.41%
62,709
+1,857
+3% +$50.9K
VYM icon
16
Vanguard High Dividend Yield ETF
VYM
$81.1B
$1.9M 1.38%
28,632
+494
+2% +$31.9K
LNT icon
17
Alliant Energy
LNT
$19.4B
$1.78M 1.29%
58,348
+3,000
+5% +$86.9K
MDT icon
18
Medtronic
MDT
$107B
$1.71M 1.24%
26,836
+365
+1% +$22.2K
JCI icon
19
Johnson Controls International
JCI
$87.5B
$1.67M 1.21%
31,980
+554
+2% +$27.6K
GILD icon
20
Gilead Sciences
GILD
$161B
$1.59M 1.16%
19,205
+3,075
+19% +$239K
PFE icon
21
Pfizer
PFE
$140B
$1.57M 1.14%
55,799
+3,457
+7% +$98.5K
CL icon
22
Colgate-Palmolive
CL
$72.6B
$1.57M 1.14%
23,023
+100
+0.4% +$6.7K
NVS icon
23
Novartis
NVS
$295B
$1.57M 1.14%
19,301
-23
-0.1% -$1.81K
IBM icon
24
IBM
IBM
$202B
$1.55M 1.13%
8,968
+465
+5% +$83.7K
T icon
25
AT&T
T
$165B
$1.54M 1.12%
57,644
-47
-0.1% -$1.26K

Similar funds

Oarsman Capital's Q2 2014 Portfolio in Review

As of Q2 2014, Oarsman Capital held 173 positions worth $138M, up 6.4% from $130M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Oarsman Capital's Q2 2014 filing shows 6 new, 77 increased, 58 reduced and 4 closed positions. Its largest new stake was Valero Energy: 7,400 shares worth $371K. The largest sale was Helen of Troy, an estimated $839K.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, up from 13% a quarter earlier, followed by Technology and Industrials.

  • Oarsman Capital's largest Q2 2014 buy was Valero Energy: 7,400 shares worth $371K.
  • Oarsman Capital added most to Fiserv Inc in Q2 2014, an estimated $621K increase.
  • Oarsman Capital's biggest Q2 2014 reduction was INTEGRYS ENERGY GROUP INC COM (USA), cutting an estimated $782K.
  • Oarsman Capital fully exited Helen of Troy in Q2 2014, selling an estimated $839K.
  • Oarsman Capital's ten largest holdings make up 20% of its $138M portfolio in Q2 2014.
  • Oarsman Capital opened 6 new positions and closed 4 in Q2 2014.
  • Oarsman Capital's portfolio value rose 6.4% quarter-over-quarter to $138M.

Based on Oarsman Capital's 13F filing for Q2 2014, filed 8 Aug 2014.